LeMaitre Vascular, Inc. (LMAT) to Issue Quarterly Dividend of $0.25 on September 3rd

LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) announced a quarterly dividend on Tuesday, July 28th. Shareholders of record on Thursday, August 20th will be given a dividend of 0.25 per share by the medical instruments supplier on Thursday, September 3rd. This represents a c) dividend on an annualized basis and a yield of 1.2%. The ex-dividend date is Thursday, August 20th.

LeMaitre Vascular has increased its dividend by an average of 0.2%annually over the last three years and has increased its dividend every year for the last 14 years. LeMaitre Vascular has a payout ratio of 42.0% meaning its dividend is sufficiently covered by earnings. Research analysts expect LeMaitre Vascular to earn $3.17 per share next year, which means the company should continue to be able to cover its $1.00 annual dividend with an expected future payout ratio of 31.5%.

Get LeMaitre Vascular alerts:

LeMaitre Vascular Stock Up 0.2%

NASDAQ LMAT opened at $82.51 on Tuesday. LeMaitre Vascular has a 1-year low of $78.65 and a 1-year high of $118.01. The company has a market capitalization of $1.89 billion, a price-to-earnings ratio of 28.95, a PEG ratio of 2.38 and a beta of 0.53. The stock’s 50 day moving average is $95.25 and its two-hundred day moving average is $99.75. The company has a current ratio of 16.31, a quick ratio of 13.96 and a debt-to-equity ratio of 0.40.

LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) last posted its earnings results on Tuesday, August 4th. The medical instruments supplier reported $0.74 EPS for the quarter, missing the consensus estimate of $0.81 by ($0.07). LeMaitre Vascular had a return on equity of 15.63% and a net margin of 25.02%.The company had revenue of $70.38 million for the quarter, compared to the consensus estimate of $71.47 million. During the same quarter last year, the business earned $0.60 EPS. LeMaitre Vascular’s quarterly revenue was up 9.6% compared to the same quarter last year. Equities analysts forecast that LeMaitre Vascular will post 2.89 earnings per share for the current fiscal year.

LeMaitre Vascular Company Profile

(Get Free Report)

LeMaitre Vascular, Inc is a specialty medical device company focused on the development, manufacture and marketing of products for the treatment of peripheral vascular disease. Headquartered in Burlington, Massachusetts, the company’s offerings include a broad portfolio of vascular surgical instruments, grafts, patches, catheters and embolic protection devices. LeMaitre’s product lines address key areas such as arterial reconstruction, endovascular repair and vascular access, serving the needs of cardiovascular surgeons and interventional specialists.

Founded in 1983 by George D.

See Also

• Five stocks we like better than LeMaitre Vascular
• Commodities Are Booming, But These 3 ETFs Tell Different Stories
• 3 Active ETFs Making Big Moves in August
• This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
• Birkenstock Beats the Skeptics—But Not on EPS

Receive News & Ratings for LeMaitre Vascular Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LeMaitre Vascular and related companies with MarketBeat.com's FREE daily email newsletter.